Rat neutrophil lysate |
2DE, HPLC |
MALDI-TOF, LC-ESI-MS/MS |
52 proteins identified |
Bovine neutrophil lysate |
1DE, HPLC(RP) |
LC-ESI-MS/MS |
250 proteins identified |
Storage granules |
2DE, gel-free HPLC (RP/SCX) |
2DE/MALDI-TOF, LC-ESI-MS/MS |
2DE/MALDI identified 87 proteins ESI-MS/MS identified 247 proteins |
Lipid rafts |
1DE |
LC-FT-ICR MS/MS |
106 proteins identified |
Lipid raft cytoskeleton |
1DE |
MALDI-TOF, MS/MS |
23 proteins identified |
Secretory vesicles and plasma membrane fractions |
1DE, free-flow electrophoresis |
MALDI-TOF, HPLC-MS/MS |
MALDI identified 27 proteins HPLC-MS/MS identified 80 proteins |
Secretory vesicles and plasma membrane fractions |
2D HPLC (SCX/RP) |
LC-MS/MS |
1118 total proteins identified, including 337 integral membrane proteins |
Phagosomes |
2DE |
MALDI-TOF, LC-MS/MS |
198 proteins identified, including ER machinery |
Phagosome and plasma membrane skeletons |
2DE |
MALDI-TOF |
138 proteins identified, metabolic enzymes associate with the cytoskeleton |
Neutrophil lysate |
2D-DIGE |
LC-MS/MS |
FPRLR-1 ligation (de)phosphorylates cytoskeletal proteins |
Neutrophil lysate |
2D-DIGE |
MALDI-TOF/TOF |
Cross-linking CD69 enhanced expression of S100A9 |
Neutrophil lysate |
2DE |
MALDI-TOF |
Pharmacologic inhibition of p38 attenuated 18% of LPS-regulated proteins by ≥ 40% |
Brochoalveolar lavage fuid |
2D-DIGE |
MALDI-TOF/TOF |
Identified 3 proteins having MMP2 and 9 cleavage sites: Ym1, S100A8, S100A9 |
Structural |
Neutrophil lysate |
IP, 2DE |
MADLI-TOF |
Identified GABABR2 as an AKT substrate |
Functional |
Immunoaffinity-purified cytochrome b
|
1DE |
MALDI, LC-MS/MS |
Reported extensive sequence coverage and PTMs for Cyt b
|
Neutrophil lysate |
1DE |
MALDI |
Identified substrates of MAPKAPK2, including 14-3-3ζ |
Neutrophil lysate |
2DE |
MALDI |
Identified substrates of MAPKAPK2, including p16-Arc of Arp2/3 |
Neutrophil lysate |
2DE |
MALDI |
Identified substrates of p38 MAPK, including MRP-14 |